LD2D.1Y

ICD-11 MMS 2026-01

Other specified neurofibromatoses

Exclusions from above levels

  • 2E83.Z – Enchondromatosis
  • 4A01.31 – Ataxia-telangiectasia
  • 8C21.1 – familial dysautonomia [Riley-Day]
Show allHide
  • LA90.00 – Rendu-Osler-Weber disease
  • LD23 – Sturge-Weber syndrome
  • LD26.60 – Angio-osteohypertrophic syndrome
  • LD2C – Proteus syndrome
  • LD2F.1Y – Maffucci syndrome
  • http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism

Sibling codes

  • LD2D.10 – Neurofibromatosis type 1
  • LD2D.11 – Neurofibromatosis type 2
  • LD2D.12 – Neurofibromatosis type 3
  • LD2D.1Z – Neurofibromatosis, unspecified

Foundation entity

Neurofibromatoses – http://id.who.int/icd/entity/1697803519

Part of: LD2D.1: Neurofibromatoses › LD2D: Phakomatoses or hamartoneoplastic syndromes › 20: Developmental anomalies